Subscription details
The IPO, which opened on September 25 and closed on September 29, was subscribed 1.28 times overall. The non-institutional investor (NII) portion drew stronger demand at 1.63 times, while the retail segment saw muted interest at just 0.35 times subscription.
The issue comprised a fresh issue of Rs 44.75 crore and an offer for sale (OFS) of Rs 4.51 crore. Proceeds will be used for working capital, expansion of the company’s Shop-in-Shop (SIS) model, and other corporate purposes.
About the company
Earkart is a HealthTech platform specializing in hearing aids and assistive devices. Its product range includes multiple types of modern hearing aids—Receiver-in-Canal (RIC), Invisible (IIC), Behind-the-Ear (BTE), In-the-Ear (ITE), and Completely-in-Canal (CIC).
The company also distributes foldable walkers and educational material for the physically challenged. It is a registered supplier to the government’s ALIMCO scheme under the Ministry of Social Justice and Empowerment.
Financials
Earkart posted robust growth in FY25, with revenue up 35% to Rs 43.2 crore and net profit more than doubling to Rs 6.9 crore, compared with Rs 3.1 crore a year earlier. EBITDA rose to Rs 9.8 crore.
With a flat GMP and lukewarm retail demand, Earkart’s listing may open without fireworks, making post-listing performance crucial to investor sentiment.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)